Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1;34(1):10-14.
doi: 10.1097/GCO.0000000000000760.

Cell-based immunotherapies in gynecologic cancers

Susan M Lang  1 , Oliver Dorigo
Affiliations
Review

Cell-based immunotherapies in gynecologic cancers

Susan M Lang et al. Curr Opin Obstet Gynecol. .

Abstract

Purpose of review: This review provides an update on recent developments in cell-based immunotherapy in gynecologic cancers.

Recent findings: Chimeric antigen receptor (CAR) technology has made significant progress allowing now for not only expressing CARs on T-cells, but also on other immune effector cells, such as natural killer cells and macrophages. Cell-based vaccines have started to show promising results in clinical trials.

Summary: Cell-based immunotherapies in gynecologic cancers continue to evolve with promising clinical efficacy in select patients.

PubMed Disclaimer

References

    1. Baci D, Bosi A, Gallazzi M, et al. The Ovarian Cancer Tumor Immune Microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors. Int J Mol Sci 2020; 21:3125.
    1. Weber EW, Maus MV, Mackall CL. The emerging landscape of immune cell therapies. Cell 2020; 181:46–62.
    1. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348:203–213.
    1. Hao J, Yu H, Zhang T, et al. Prognostic impact of tumor-infiltrating lymphocytes in high grade serous ovarian cancer: a systematic review and meta-analysis. Ther Adv Med Oncol 2020; 12: 1758835920967241.
    1. Santoiemma PP, Powell DJ Jr. Tumor infiltrating lymphocytes in ovarian cancer. Cancer Biol Ther 2015; 16:807–820.

Substances